NCT03398785View on ClinicalTrials.gov

Adrenal Artery Ablation Treats Primary Aldosteronism

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

June 30, 2019

Conditions
Primary AldosteronismHypertension
Interventions
PROCEDURE

Endovascular chemical Ablation of Adrenal Gland

Patients in this group will be treated with partial ablation of adrenal gland by endovascular injection of dehydrated alcohol.

Trial Locations (1)

400042

The third hospital affiliated to the Third Military Medical University, Chongqing

All Listed Sponsors
lead

Third Military Medical University

OTHER

NCT03398785 - Adrenal Artery Ablation Treats Primary Aldosteronism | Biotech Hunter | Biotech Hunter